In SUM159 and SCP2 human tumor cells, as model cells for triple-negative breast cancer, CBD effectively inhibited epidermal growth factor (EGF)-induced tumorigenic properties of these cancer cells by obstructing signaling pathways for EGFR, Akt, ERK, and NF-κB. This evidence concerns the gene EGF and cancer.